Study title:
Neuro Endocrinol Lett. 2006 Oct;27(5):587-94. Regional brain metabolism as the predictor of performance on the Trail Making
Test in schizophrenia. A 18FDG PET covariation study. Horacek J, Dockery C, Kopecek M, Spaniel F, Novak T, Tislerova B, Klirova M,
Palenicek T, HÃschl C.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Nervous System Diseases [C10]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: FLUDEOXYGLUCOSE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
Y
|